User ID
  Password
  Language
  Protocol
 
  
  
About
View Full Text
For Contributors
submit paper
 
 
 
Abstract - Case Report

J Cerebrovasc Endovasc Neurosurg. 2020 22(4): 273-281
The Journal of Cerebrovascular and Endovascular Neurosurgery
      
 
Jugular foramen paragangliomas: preoperative transcatheter particle embolization
Varun Danda
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA

Jugular foramen paragangliomas (JFP) are benign tumors of neural crest origin that are located along the temporal bone in the region of the jugular bulb and middle ear. The optimal management of these lesions includes surgical excision with or without preoperative embolization as well as stereotactic radiotherapy. The use of preoperative embolization in the treatment of JFP has shown great promise to bridge patients to surgery by diminishing complication rates and decreasing intraoperative bleeding. We present three successful polyvinyl alcohol (PVA) particle embolizations of patients presenting with symptomatic JFPs. All patients recovered completely in the short term with no bleeding during or after resection of paragangliomas and they were discharged free of their presenting symptoms. Early clinical and imaging diagnosis followed by adequate treatment including preoperative transcatheter particle embolization and surgical or radiosurgical interventions can lead to excellent outcomes.
 
Key words : Embolization, Tumor, Paraganglioma, Pre-operative, Endovascular, Mass
 
 
    
 
 
 

Editorial Office Contact Information
The Journal of Cerebrovascular and Endovascular Neurosurgery (JCEN), Department of Neurosurgery, Wonkwang University
School of Medicine and Hospital, 895, Muwang-ro, Iksan-si, Jeollabuk-do 54538, Korea.
Tel. 82-02-2279-9560, Fax. 82-02-2279-9561, E-mail: editor.jcen@the-jcen.org, Dae-Won Kim
 
This site is available under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 South Korea License (CC BY-NC-SA 4.0);
and the PDF can be downloaded freely. By using this site, you agree to the Terms of Use and Privacy Policy.